SEX DIFFERENCES IN PHARMACOLOGIC OPTIMAL MEDICAL THERAPY FOR ISCHEMIC HEART DISEASE, 2010-2020: AN OBSERVATIONAL STUDY.

ABSTRACT:

Background

Despite guideline recommendations for optimal medical therapy (OMT) in the secondary prevention of ischemic heart disease (IHD)-including antiplatelets, statins, renin-angiotensin-aldosterone system inhibitors (RAASi), and β-blockers-substantial sex disparities in OMT utilization persist. The extent to which national efforts have mitigated these disparities in contemporary cohorts remains unclear.

Methods

We analyzed data from the 2011-2020 National Health and Nutrition Examination Survey (NHANES) cycles, identifying adults with self-reported IHD (defined as a history of myocardial infarction or coronary heart disease). OMT use in the preceding 30 days was assessed based on participant report and verified through medication containers when available. We evaluated

SUBMITTER: Alhassan HA 

PROVIDER: S-EPMC12265793 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature